The extracellular matrix: Focus on oligodendrocyte biology and targeting CSPG s for remyelination therapies
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The repair of myelin, termed remyelination, is a regenerative process that occurs within the central nervous system in conditions such as multiple sclerosis. Remyelination is enabled by oligodendrocytes that mature from oligodendrocyte precursor cells. Many factors influence the biology of oligodendrocytes and their capacity to reform myelin, and considerable evidence now implicates the extracellular matrix within the injured central nervous system as a major modifier of remyelination. Herein, we review current knowledge of components of the brain extracellular matrix that are beneficial or inhibitory for oligodendrocyte recruitment and maturation, and for their capacity to remyelinate where evidence exists. We highlight the detrimental roles of the chondroitin sulfate proteoglycans in remyelination and discuss approaches to alter the brain extracellular matrix for the wellbeing of oligodendrocytes and their capacity for myelin regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ricard-Blum, S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004978 · Cited by 2,305
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664 · cited 2×
“, 1998) and provision of energy metabolites such as lactate (Lee et al., 2012).”
BackgroundRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 1×
“The reader is referred elsewhere to comprehensive reviews on factors that influence the capacity to remyelinate (Franklin & ffrench-Constant, 2008; Keough & Yong, 2013).”
BackgroundNegative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378 · cited 1×
“Importantly, TLR2 appears to only be stimulated by low molecular weight hyaluronan (Scheibner et al., 2006; Termeer et al., 2002), implicating this form of hyaluronan to be the repressive species for OPC maturation.”
BackgroundMatrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274 · cited 2×
“Homeostatically, MMPs serve roles both indirectly and directly in cell growth, regulation of apoptosis, cell migration, and cell-cell communication (McCawley & Matrisian, 2001).”
BackgroundMyelination and support of axonal integrity by glia
Nave, K.-A. (2010) · Nature · doi:10.1038/nature09614 · Cited by 1,062
Fitch, M. T., & Silver, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.014 · Cited by 1,007 · cited 2×
“CSPGs are one of the primary constituents of the glial scar (Beggah et al., 2005; Fitch & Silver, 2008; Galtrey & Fawcett, 2007).”
BackgroundHyaluronic acid (hyaluronan): A review
Necas, J., Bartosikova, L., Brauner, P., & Kolar, J. (2008) · Veterinární medicína · doi:10.17221/1930-vetmed · Cited by 998
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889 · cited 2×
“Myelin itself is also known to interact with the axon in different ways, including support of axonal structure (Griffiths et al., 1998) and provision of energy metabolites such as lactate (Lee et al., 2012).”
BackgroundHyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2
Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., & Horton, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1272 · Cited by 708 · cited 1×
“Importantly, TLR2 appears to only be stimulated by low molecular weight hyaluronan (Scheibner et al., 2006; Termeer et al., 2002), implicating this form of hyaluronan to be the repressive species for OPC maturation.”
BackgroundRecent advances in the structural biology of chondroitin sulfate and dermatan sulfate
Sugahara, K., Mikami, T., Uyama, T., Mizuguchi, S., Nomura, K., & Kitagawa, H. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.09.011 · Cited by 694
Mechanisms of axon ensheathment and myelin growth
Sherman, D. L., & Brophy, P. J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1743 · Cited by 668 · cited 2×
“We refer readers to thorough reviews on the biology of oligodendrocytes, the mechanisms of myelination and oligodendrocyte-axon interaction (Emery, 2010; Sherman & Brophy, 2005; Nave, 2010; Micu, Plemel, Caprariello, Nave, & Stys, 2017; Plemel, Liu, & Yong, 2017).”
BackgroundMethodRegulation of oligodendrocyte differentiation and myelination
Emery, B. (2010) · Science · doi:10.1126/science.1190927 · Cited by 653 · cited 2×
“We refer readers to thorough reviews on the biology of oligodendrocytes, the mechanisms of myelination and oligodendrocyte-axon interaction (Emery, 2010; Sherman & Brophy, 2005; Nave, 2010; Micu, Plemel, Caprariello, Nave, & Stys, 2017; Plemel, Liu, & Yong, 2017).”
BackgroundMethodProteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins
Bandtlow, C. E., & Zimmermann, D. R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1267 · Cited by 632
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation
Back, S. A., Tuohy, T. M. F., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N. L., Banine, F., Liu, Y., Chang, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1279 · Cited by 612 · cited 2×
“Hyaluronan accumulates in both active and chronic lesions (Back et al., 2005).”
BackgroundGreen, A. J., Gelfand, J. M., Cree, B. A., Bevan, C., Boscardin, W. J., Mei, F., Inman, J., Arnow, S., Devereux, M., Abounasr, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32346-2 · Cited by 593 · cited 1×
“A LINGO-1 antagonist (Clinicaltrials.gov NCT01864148) and clemastine (Green et al., 2017) are such examples that have recently completed phase 2 clinical trials.”
BackgroundGaltrey, C. M., & Fawcett, J. W. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.006 · Cited by 575 · cited 2×
“CSPGs are one of the primary constituents of the glial scar (Beggah et al., 2005; Fitch & Silver, 2008; Galtrey & Fawcett, 2007).”
BackgroundMultiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574
Wolswijk, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00601.1998 · Cited by 562
Pathophysiology of the brain extracellular matrix: a new target for remyelination
Lau, L. W., Cua, R., Keough, M. B., Haylock-Jacobs, S., & Yong, V. W. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3550 · Cited by 549 · cited 2×
“In this light, ADAMTSs may be a more promising approach than MMPs to remove inhibitory CSPGs as they are less neurotoxic than MMPs (Lau et al., 2013).”
BackgroundSelf-citationEndogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544 · cited 1×
“Remyelination requires the replenishment and maturation of oligodendrocyte precursor cells (OPCs) (Gensert & Goldman, 1997; Jarjour & Kennedy, 2004) that extend processes to contact and ensheath axons (Emery, 2010; Sherman & Brophy, 2005).”
BackgroundRegulatory T cells promote myelin regeneration in the central nervous system
Dombrowski, Y., O'Hagan, T., Dittmer, M., Penalva, R., Mayoral, S. R., Bankhead, P., Fleville, S., Eleftheriadis, G., Zhao, C., Naughton, M., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4528 · Cited by 533 · cited 1×
“The recent report that Tregs promote remyelination is attributed to their production of the secreted ECM-associated signaling protein nephroblastoma overexpressed (NOV, CCN3; Dombrowski et al., 2017).”
BackgroundBasement membrane proteoglycans: from cellar to ceiling
Iozzo, R. V. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1702 · Cited by 521 · cited 1×
“Their largely structural role is mediated in part by associating with collagen IV networks through nidogen-1 (Takagi, Yang, Liu, Wang, & Springer, 2003) and perlecan (Iozzo, 2005).”
BackgroundFischer, M. T., Sharma, R., Lim, J. L., Haider, L., Frischer, J. M., Drexhage, J., Mahad, D., Bradl, M., van Horssen, J., & Lassmann, H. (2012) · Brain · doi:10.1093/brain/aws012 · Cited by 507
Extracellular Matrix: Functions in the Nervous System
Barros, C. S., Franco, S. J., & Muller, U. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005108 · Cited by 506
Synthesis and sorting of proteoglycans
Prydz, K., & Dalen, K. T. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.2.193 · Cited by 481
McKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Extracellular matrix and perineuronal nets in CNS repair
Kwok, J. C. F., Dick, G., Wang, D., & Fawcett, J. W. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20974 · Cited by 395 · cited 1×
“Hyaluronan is an essential component of the perineuronal net, connecting to multiple CSPGs in order to create an organized network (Kwok et al., 2011).”
BackgroundThe perineuronal net and the control of CNS plasticity
Wang, D., & Fawcett, J. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1375-y · Cited by 373 · cited 1×
“During development, CSPGs provide guidance cues for axonal growth cones (Laabs, Carulli, Geller, & Fawcett, 2005), and in late development are found in perineuronal nets surrounding neural soma (Carulli et al., 2006; Kwok, Dick, Wang, & Fawcett, 2011; Lau et al., 2013; Wang & Fawcett, 2012).”
BackgroundCarulli, D., Rhodes, K. E., Brown, D. J., Bonnert, T. P., Pollack, S. J., Oliver, K., Strata, P., & Fawcett, J. W. (2006) · Journal of Comparative Neurology · doi:10.1002/cne.20822 · Cited by 341
Woodruff, R. H., Fruttiger, M., Richardson, W. D., & Franklin, R. J. M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.014 · Cited by 335
Extensive cortical remyelination in patients with chronic multiple sclerosis
Albert, M., Antel, J., Brück, W., & Stadelmann, C. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00043.x · Cited by 314
Extensive remyelination of the CNS leads to functional recovery
Duncan, I. D., Brower, A., Kondo, Y., Curlee, J. F., & Schultz, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812500106 · Cited by 227
The benefits and detriments of macrophages/microglia in models of multiple sclerosis
Rawji, K. S., & Yong, V. W. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/948976 · Cited by 217 · cited 1×
“…persistently activated microglia can elaborate toxic factors including reactive oxygen species that promote lesion injury (Fischer et al., 2012), but these cells and macrophages are necessary for removal of myelin debris that otherwise would impair remyelination (reviewed in Rawji & Yong, 2013).”
BackgroundCortical remyelination: A new target for repair therapies in multiple sclerosis
Chang, A., Staugaitis, S. M., Dutta, R., Batt, C. E., Easley, K. E., Chomyk, A. M., Yong, V. W., Fox, R. J., Kidd, G. J., & Trapp, B. D. (2012) · Annals of Neurology · doi:10.1002/ana.23693 · Cited by 216 · cited 1×
“…in demyelinated white matter (Lassmann, Br€uck, Lucchinetti, & Rodriguez, 1997; Patrikios et al., 2006; Prineas, Barnard, Kwon, Sharer, & Cho, 1993; Prineas & Connell, 1979) and more recently in cortical grey matter (Albert, Antel, Br€uck, & Stadelmann, 2007; Chang et al., 2012) MS plaques.”
Self-citationRemyelination in multiple sclerosis
Lassmann, H., Brück, W., Lucchinetti, C., & Rodriguez, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300213 · Cited by 191
Armstrong, R. C., Le, T. Q., Frost, E. E., Borke, R. C., & Vana, A. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08574.2002 · Cited by 178 · cited 1×
“Importantly, OPCs express FGF2 and PDGF ligands and receptors in response to demyelination (Armstrong et al., 2002; Frost, Nielsen, Le, & Armstrong, 2003; Redwine & Armstrong, 1998).”
BackgroundMurtie, J. C., Zhou, Y.-X., Le, T. Q., Vana, A. C., & Armstrong, R. C. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.006 · Cited by 157
Selvaraju, R., Bernasconi, L., Losberger, C., Graber, P., Kadi, L., Avellana-Adalid, V., Picard-Riera, N., Van Evercooren, A. B., Cirillo, R., Kosco-Vilbois, M., et al. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.12.014 · Cited by 156
Extensive extracellular matrix depositions in active multiple sclerosis lesions.
van Horssen, J., Bö, L., Dijkstra, C. D., & de Vries, H. E. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.005 · Cited by 119
Yuan, W., Matthews, R. T., Sandy, J. D., & Gottschall, P. E. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00347-0 · Cited by 109
Digestion products of the PH20 hyaluronidase inhibit remyelination
Preston, M., Gong, X., Su, W., Matsumoto, S. G., Banine, F., Winkler, C., Foster, S., Xing, R., Struve, J., Dean, J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23788 · Cited by 107 · cited 1×
“Digestion products of the hyaluronidase PH20 expressed by OPCs and reactive astrocytes have also been reported to inhibit OPC maturation and remyelination in lysolecithin-induced demyelination (Preston et al., 2013).”
BackgroundTauchi, R., Imagama, S., Natori, T., Ohgomori, T., Muramoto, A., Shinjo, R., Matsuyama, Y., Ishiguro, N., & Kadomatsu, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-53 · Cited by 91
Larsen, P. H., & Yong, V. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2092-04.2004 · Cited by 64
Self-citationLee, K. K., De Repentigny, Y., Saulnier, R., Rippstein, P., Macklin, W. B., & Kothary, R. (2006) · Glia · doi:10.1002/glia.20343 · Cited by 59
Blakemore, W. F., & Murray, J. A. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90084-8 · Cited by 53
Cited by
The pro-remyelination properties of microglia in the central nervous system
Lloyd, A. F., & Miron, V. E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0184-2 · Cited by 381
Remyelination in multiple sclerosis: From basic science to clinical translation
Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C., & Stankoff, B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30140-x · Cited by 350
Scalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10
Metadata
- Authors
- Pu, A., Stephenson, E. L., & Yong, V. W.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2018-03-30
- Volume
- 66
- Issue
- 9
- Pages
- 1809-1825
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2795226545
- Cited by
- 76
- References
- 49
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.